The move strengthens Hong Kong-Malaysia connectivity and expands regional product reach.
Hang Seng Indexes Company Ltd (HSIL) has licensed the Hang Seng Biotech Index for warrant issuance to Kuala Lumpur-based Kenanga Investment Bank Berhad (Kenanga), marking its first overseas warrant licensing for the benchmark. By extending our indices into overseas markets, we are strengthening connectivity between Hong Kong and Malaysia - Gilbert Lee, HSIL Consequently, Kenanga will launch the products as part of a broader push to expand index-linked offerings outside Hong Kong SAR (HKSAR).